MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art…
Read moreabout MedPharm’s CSO Co-authors New Book on Formulation DevelopmentNews
Destiny Pharma appoints MedPharm to develop new XF‐platform drug formulations as treatments for dermal and ocular infections. MedPharm is pleased to announce it’s…
Read moreabout MedPharm to develop new XF-drug formulations
MedPharm has announced two new appointments to its board to support plans to grow its commercial manufacturing services. The new members, Paul Johnson…
Read moreabout MedPharm Accelerates Progression Into Commercial Manufacturing
We are pleased to partner with NC State University Graduate School’s Accelerate to Industry (A2i) Summer Industry Immersion programme. Jon Volmer, our Senior…
Read moreabout We’ve Partnered with NC State to Support its A2i Programme
MedPharm Ltd has announced the expansion of its US Center of Excellence in Durham, North Carolina in response to increasing service demand for…
Read moreabout MedPharm announces expansion of US Center of Excellence
We are pleased to announce that Eugene Ciolfi has joined as its President and Chief Executive Officer. In conjunction with his hiring, he…
Read moreabout Introducing our new CEO & President: Eugene Ciolfi
MedPharm’s performance testing models help to support client’s to understand the potential applications of their products MedPharm’s unique expertise to model the behaviour…
Read moreabout MedPharm’s Technical Expertise Expands the Potential Applications of Products
MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita MedPharm Ltd have…
Read moreabout MedPharm Expands Partnership with Palvella
MedPharm are pleased to announce that we have been shortlisted for an award at this year’s CPhI Pharma Awards. We are excited to…
Read moreabout MedPharm are Finalists at CPhI Pharma Awards 2018
MedPharm has validated proprietary models for measuring the permeation, penetration and efficacy of customer’s products into and across the nail In a recent…
Read moreabout Novel In Vitro Nail Models for Topical Development